Venrock Healthcare Capital Partners III, L.P. 13D and 13G filings for Praxis Precision Medicines, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-05-15 5:45 pm Sale |
2025-03-31 | 13G | Praxis Precision Medicines, Inc. PRAX |
Venrock Healthcare Capital Partners III, L.P. | 1,016,497 4.900% |
-173,843 (-14.60%) |
Filing |
| 2025-02-14 6:08 pm Purchase |
2024-12-31 | 13G | Praxis Precision Medicines, Inc. PRAX |
Venrock Healthcare Capital Partners III, L.P. | 1,190,340 6.100% |
283,854 (+31.31%) |
Filing |
| 2024-11-14 5:50 pm Purchase |
2024-09-30 | 13G | Praxis Precision Medicines, Inc. PRAX |
Venrock Healthcare Capital Partners III, L.P. | 906,486 5.000% |
82,860 (+10.06%) |
Filing |
| 2024-02-14 8:45 pm Purchase |
2023-12-31 | 13G | Praxis Precision Medicines, Inc. PRAX |
Venrock Healthcare Capital Partners III, L.P. | 823,626 8.900% |
823,626 (New Position) |
Filing |